Quantcast

Latest Hematological malignancy Stories

2013-03-21 14:58:25

Researchers at Moffitt Cancer Center have completed a phase II clinical trial to determine the safety and efficacy of dasatinib for patients with higher-risk myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia, or acute myeloid leukemia resulting from MDS and have failed treatment with azanucleosides. The therapy may not be effective for all patients, but those with trisomy 8 chromosomal disorder have higher rates of stable disease and respond better to treatment with dasatinib,...

2013-02-13 23:01:38

Workshop will discuss minimal residual disease (MRD) as a possible response in group of hematological malignancies New York, NY (PRWEB) February 13, 2013 TalkPoint, the industry leader in global communications technology, specializing in browser-based audio and video webcasting, and FDAAdvisoryCommittee.com (FDAAC.com), the leading provider of live video webcasts of the Food and Drug Administration (FDA) Advisory Committee meetings, today announced it is partnership for a series of FDA...


Word of the Day
mallemaroking
  • Nautical, the visiting and carousing of sailors in the Greenland ships.
This word is apparently from a confusion of two similar Dutch words: 'mallemerok,' a foolish woman, and 'mallemok,' a name for some persons among the crew of a whaling vessel.